A detailed history of Reap Financial Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Reap Financial Group, LLC holds 136 shares of BSX stock, worth $13,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136
Previous 176 22.73%
Holding current value
$13,708
Previous $14.7 Million 17.64%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 27, 2025

SELL
$83.62 - $91.5 $3,344 - $3,660
-40 Reduced 22.73%
136 $12.1 Million
Q3 2024

Feb 27, 2025

BUY
$72.96 - $84.0 $2,845 - $3,276
39 Added 28.47%
176 $14.7 Million
Q2 2024

Feb 27, 2025

BUY
$67.33 - $77.71 $2,827 - $3,263
42 Added 44.21%
137 $10.6 Million
Q1 2024

Feb 27, 2025

SELL
$57.6 - $68.62 $288 - $343
-5 Reduced 5.0%
95 $6.51 Million
Q4 2023

Feb 27, 2025

BUY
$48.64 - $57.81 $4,864 - $5,781
100 New
100 $5.78 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $144B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Reap Financial Group, LLC Portfolio

Follow Reap Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reap Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reap Financial Group, LLC with notifications on news.